Coherus BioSciences
CHRS
#8871
Rank
โ‚น7.57 B
Marketcap
โ‚น65.71
Share price
-5.44%
Change (1 day)
-54.08%
Change (1 year)

Revenue for Coherus BioSciences (CHRS)

Revenue in 2024 (TTM): โ‚น25.66 Billion

According to Coherus BioSciences 's latest financial reports the company's current revenue (TTM ) is โ‚น26.00 Billion. In 2023 the company made a revenue of โ‚น21.41 Billion an increase over the revenue in the year 2022 that were of โ‚น17.46 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Coherus BioSciences from 2014 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น25.66 B19.84%
2023 โ‚น21.41 B22.63%
2022 โ‚น17.46 B-28.15%
2021 โ‚น24.30 B-30.15%
2020 โ‚น34.79 B37.05%
2019 โ‚น25.39 B
2018 N/A-100%
2017 โ‚น99.35 M-99.23%
2016 โ‚น12.91 B547.1%
2015 โ‚น1.99 B1.27%
2014 โ‚น1.97 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น9.76 B-62.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น31.47 M-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.745 T 10,458.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น50.82 B 95.48%๐Ÿ‡บ๐Ÿ‡ธ USA